Early kinetics of C-reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: A multi-center cohort study

被引：0

作者：

Barth, D. ^{[1
]}

Moik, F. ^{[1
]}

Steinlechner, S. M. ^{[1
]}

Posch, F. ^{[2
]}

Schlintl, V. ^{[1
]}

Koch, L. ^{[3
]}

John, N. ^{[4
]}

Wurm, R. ^{[4
]}

Pichler, M. ^{[1
]}

Bauernhofer, T. ^{[1
]}

Reimann, P. ^{[5
]}

Wohlkoenig, C. ^{[4
]}

Richtig, E. ^{[3
]}

Winder, T. ^{[5
]}

Preusser, M. ^{[6
]}

Jost, P. J. ^{[1
]}

Ay, C. ^{[7
]}

Gerger, A. ^{[1
]}

Terbuch, A. ^{[1
]}

Riedl, J. M. ^{[1
]}

机构：

[1] Med Univ Graz, Div Oncol, Dept Internal Med, Graz, Austria

[2] Med Univ Graz, Div Hematol, Dept Internal Med, Graz, Austria

[3] Med Univ Graz, Dept Dermatol, Graz, Austria

[4] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria

[5] Landeskrankenhaus Feldkirch, Dept Oncol, Feldkirch, Austria

[6] Med Univ Vienna, Div Oncol, Dept Med 1, Vienna, Austria

[7] Med Univ Vienna, Dept Med 1, Clin Div Haematol & Haemostaseol, MedUni Wien, Vienna, Austria

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.2917

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

194P

引用

页码：S259 / S259

页数：1

共 50 条

[1] Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study
Barth, Dominik A.
Moik, Florian
Steinlechner, Sarah
Posch, Florian
Mayer, Marie-Christina
Sandner, Amelie M.
Berton, Franziska
Schlintl, Verena
Koch, Lukas
John, Nikolaus
Wurm, Robert
Pichler, Martin
Bauernhofer, Thomas
Reimann, Patrick
Wohlkoenig, Christoph
Richtig, Erika
Winder, Thomas
Preusser, Matthias
Jost, Philipp J.
Ay, Cihan
Gerger, Armin
Terbuch, Angelika
Riedl, Jakob Michael
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (12)
[2] Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors
Moik, Florian
Riedl, Jakob
Barth, Dominik
Chan, Wei-Shin Evelyn
Wiedemann, Sarah
Hoeller, Christoph
Fuereder, Thorsten
Jost, Philipp
Pabinger, Ingrid
Preusser, Matthias
Ay, Cihan
BLOOD, 2022, 140 : 1250 - 1251
[3] Early C-reactive protein kinetics predict response to immune checkpoint inhibition in malignant melanoma
Koett, J.
Zimmermann, N.
Zell, T.
Heidrich, I.
Geidel, G.
Merkle, M.
Hansen, I.
Abeck, F.
Ruenger, A.
Reschke, R.
Gebhardt, C.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 49 - 49
[4] C-REACTIVE PROTEIN (CRP) AS A PROGNOSTIC BIOMARKER IN ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS. RESULTS FROM A MULTI-CENTER INTERNATIONAL OBSERVATIONAL STUDY
Naqash, Abdul Rafeh
Cortellini, Alessio
Mi, Emma
Livanainen, Sanna
Gramenitskaya, Daria
Clark, James
O'Brien, Kevin
Koivunen, Jussi
Macherla, Shravanti
Jonnalagadda, Sweta
Polsani, Shanker
Jiwani, Rahim
Sharma, Nitika
Stroud, Chipman
Muzaffar, Mahvish
Walker, Paul
Pinato, David
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A18 - A18
[5] Early kinetics of C-reactive protein as prognosticator for survival in a real-world cohort of patients with metastatic renal cell cancer under first-line therapy with immune checkpoint inhibitors
Schuettke, Vayda
Kusiek, Cathrin
Fuessel, Susanne
Thomas, Christian
Buerk, Bjoern Thorben
Erdmann, Kati
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (05): : 1117 - 1128
[6] Early kinetics of C-reactive protein as prognosticator for survival in a real-world cohort of patients with metastatic renal cell cancer under first-line therapy with immune checkpoint inhibitors
Vayda Schüttke
Cathrin Kusiek
Susanne Fuessel
Christian Thomas
Bjoern Thorben Buerk
Kati Erdmann
Clinical and Translational Oncology, 2024, 26 : 1117 - 1128
[7] Early C-reactive Protein Kinetics Predict Response to Immune Checkpoint Blockade in Unresectable Hepatocellular Carcinoma
Qin, Qiuying
Kou, Xiaoxuan
Zheng, Yuanyuan
Zhou, Fei
Zhang, Xiaoyong
Liu, Hongyan
JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 2009 - 2019
[8] A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
Murakami, Naoka
Mulvaney, Patrick
Danesh, Melissa
Abudayyeh, Ala
Diab, Adi
Abdel-Wahab, Noha
Abdelrahim, Maen
Khairallah, Pascale
Shirazian, Shayan
Kukla, Aleksandra
Owoyemi, Itunu O.
Alhamad, Tarek
Husami, Samir
Menon, Madhav
Santeusanio, Andrew
Blosser, Christopher D.
Zuniga, Sandra Carias
Soler, Maria Jose
Moreso, Francesc
Mithani, Zain
Ortiz-Melo, David
Jaimes, Edgar A.
Gutgarts, Victoria
Lum, Erik
Danovitch, Gabriel M.
Cardarelli, Francesca
Drews, Reed E.
Bassil, Claude
Swank, Jennifer L.
Westphal, Scott
Mannon, Roslyn B.
Shirai, Keisuke
Kitchlu, Abhijat
Ong, Song
Machado, Shana M.
Mothi, Suraj S.
Ott, Patrick A.
Rahma, Osama
Hodi, F. Stephen
Sise, Meghan E.
Gupta, Shruti
Leaf, David E.
Devoe, Craig E.
Wanchoo, Rimda
Nair, Vinay V.
Schmults, Chrysalyne D.
Hanna, Glenn J.
Sprangers, Ben
Riella, Leonardo V.
Jhaveri, Kenar D.
KIDNEY INTERNATIONAL, 2021, 100 (01) : 196 - 205
[9] Prognostic role of C-reactive protein to albumin ratio in cancer patients treated with immune checkpoint inhibitors: a meta-analysis
Dai, Menglu
Wu, Wei
FRONTIERS IN ONCOLOGY, 2023, 13
[10] C-reactive protein kinetics as a predictive marker for long-term outcome of immune checkpoint inhibitors in oesophagogastric cancer
Yohei Nose
Takuro Saito
Yukinori Kurokawa
Tsuyoshi Takahashi
Kazuyoshi Yamamoto
Kota Momose
Kotaro Yamashita
Koji Tanaka
Tomoki Makino
Hidetoshi Eguchi
Yuichiro Doki
Hisashi Wada
BJC Reports, 1 (1):

← 1 2 3 4 5 →